{
    "SPADE_UN_26250": {
        "Sequence Information": {
            "Peptide Name": "Ranatuerin-2Ra (1-5)-(FKVH)-(6-17)",
            "Sequence": "AVNIPFKVHFKVHFRCKAAFC",
            "Sequence Length": 21,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Antifungal",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P86020",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P86020",
                    "description": "The amino acid sequence of the current peptide coincides with the amino acid sequence of the UniProt entry."
                }
            ],
            "Literature": [
                {
                    "Title": "An Effective Modification Strategy to Build Multifunctional Peptides Based on a Trypsin Inhibitory Peptide of the Kunitz Family.",
                    "Pubmed ID": "38794259",
                    "Reference": "Pharmaceutics. 2024;16:597",
                    "Author": "Wang Y, Shi D, Zou W, Jiang Y, Wang T, Chen X, Ma C, Li W, Chen T, Burrows JF, Wang L, Zhou M",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/38794259"
                }
            ],
            "Mass": 2462.98,
            "PI": 9.85,
            "Net Charge": 6,
            "Hydrophobicity": 0.52,
            "Frequent Amino Acids": "FAK",
            "Absent Amino Acids": "DEGLMOQSTUWY",
            "Basic Residues": 6,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 13,
            "Polar Residues": 8,
            "Positive Residues": 6,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_26250",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_01106",
                    "Similarity": 1.0,
                    "Sequence": "AVNIPFKVHFRCKAAFC"
                },
                {
                    "SPADE_ID": "SPADE_N_09100",
                    "Similarity": 1.0,
                    "Sequence": "AVNIPFKVHFCAAFC"
                },
                {
                    "SPADE_ID": "SPADE_N_09101",
                    "Similarity": 1.0,
                    "Sequence": "AVNIPFVHFCKAAFC"
                }
            ],
            "Hemolytic Activity": "Horse erythrocytes:20% Hemolysis=304.2 µM,Human keratinocytes HaCat:20% Cytotoxicity =100 µM",
            "Target Organism": "Escherichia coli ATCC 8739(MIC=16µM),Escherichia coli ATCC 8739(MBC=16µM),Escherichia coli ATCC BAA-2340(MIC=16µM),Escherichia coli ATCC BAA-2340(MBC=16µM),Escherichia coli NCTC 13846(MIC=8µM),Escherichia coli NCTC 13846(MBC=16µM),Pseudomonas aeruginosa ATCC 9027(MIC=16µM),Pseudomonas aeruginosa ATCC 9027(MBC=16µM),Klebsiella pneumoniae ATCC 43816(MIC=16µM),Klebsiella pneumoniae ATCC 43816(MBC=32µM),Acinetobacter baumannii ATCC BAA-747(MIC=>512µM),Staphylococcus aureus ATCC 6538(MIC=>512µM),Enterococcus faecium NTCC 12697(MIC=>512µM),Staphylococcus aureus NCTC 12493(MIC=16µM),Staphylococcus aureus NCTC 12493(MBC=32µM),Candida albicans ATCC 10231(MIC=>512µM),Human lung adenocarcinoma NCI-H838(IC50=29.74µM),Human glioblastoma U251-MG(IC50=88.25µM),Human breast adenocarcinoma MCF-7(IC50=169µM)"
        }
    }
}